MENLO PARK, Calif., March 19, 2026 /PRNewswire/ — Endovascular Engineering, Inc. (“E2”) today announced that two abstracts related to the ENGULF study and the Hēlo® Platform have been accepted as late-breaking podium presentations at the Society of Interventional Radiology (SIR) Annual…